Pharmafile Logo
Pharmafocus logo
Advanced Search
Actavis image

Actavis and AZ see FDA approval for ‘superbug’ drug

February 27, 2015
Research and Development, Sales and Marketing Actavis, AstraZeneca, Avycaz, FDA, US, ceftazidime/avibactam

Actavis and AstraZeneca’s combo ‘superbug’ drug Avycaz has been shown the green light to treat patients with complicated intra-abdominal infections …

News
Bayer image

Bayer justifies Brandicourt’s ‘golden handshake’

February 27, 2015
Medical Communications, Sales and Marketing Bayer, CEO, Sanofi, dekkers, olivier brandicourt, payments, wages

Bayer has confirmed that Sanofi’s justification for the controversial starter package it is giving to the German firm’s Olivier Brandicourt …

News

Most Americans ready for health wearables and apps

February 27, 2015
Medical Communications, Sales and Marketing Makovsky/Kelton, Pulse of Online Health, US, app, apps, digital, wearables

Americans are ready and willing to leverage health apps and wearable devices in order to improve their personal health according …

News
richard_pott_bayer

Bayer MaterialScience gets new chairman

February 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Werner Baumann, richard pott

Dr Richard Pott has been appointed to the supervisory board at Bayer MaterialScience as its new chairman. Pott replaces Werner …

Appointment
sir_philip_hampton_gsk_chairman

GlaxoSmithKline announces board changes early

February 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Tom de Swaan, christopher gent, sir philip hampton

GlaxoSmithKline has confirmed that Sir Christopher Gent will step down early as chairman of GSK in May to be succeeded …

Appointment
Bayer image

New drugs give Bayer record sales

February 26, 2015
Sales and Marketing Bayer, Eylea, Radium-223 chloride, Stivarga, Xarelto, adempas, aflibercept, dekkers, german, regorafenib, riociguat, xofigo

Bayer has reported strong financial results for 2014 driven primary by sales of new medicines, although controversy surrounding its anti-clotting …

News
Sanofi image

Sanofi sees FDA approval for diabetes drug

February 26, 2015
Sales and Marketing Afrezza, FDA, Q2, Sanofi, Twitter, diabetes, insulin glargine, q4

US regulators have approved Sanofi’s diabetes treatment Toujeo which is said to be a follow-up to the French firms key …

News

NICE recommends hep C and bowel treatments

February 26, 2015
Sales and Marketing AbbVie, Humira, J&J, JJ, Janssen, Merck, Remicade, Simponi, olysio

Three drugs to treat chronic bowel condition ulcerative colitis and one for hepatitis C will be funded by the NHS …

News
lisa-giles

GenMark Diagnostics performs board shuffle

February 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genmark diagnostics, lisa giles, michael kagnoff

US diagnostic systems provider GenMark Diagnostics has named two new board members whilst announcing a resignation.  Lisa Giles (pictured) who …

Appointment
Eisai image

Eisai cancer drug performs in sarcoma disease

February 26, 2015
Sales and Marketing Cancer, Eisai, Halaven, eribulin, sarcoma, tumour

Eisai’s cancer drug Halaven met its primary endpoint and demonstrated overall survival benefit in two distinct solid tumour types in …

News
AZ image

AstraZeneca enters autoimmune diseases pact with Orca

February 25, 2015
Research and Development, Sales and Marketing AstraZeneca, autoimmune, orca, orphan nuclear receptor gamma inhibitors, psoriasis, retinoic

AstraZeneca has signed a three-year research deal with the UK-based biotech firm Orca to develop treatments for autoimmune diseases. The …

News
Napp image

Napp launches biosimilar in UK

February 25, 2015
Research and Development, Sales and Marketing Hospira, Napp, Remicade, anti-TNF biologic, biosimilar, infliximab, remsima

Napp Pharmaceuticals has launched its own biosimilar version of an anti-TNF biologic in Europe paving the way for patient access …

News
Sovaldi image

Gilead frustrated despite final NICE Sovaldi nod

February 25, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, sofosbuvir, sovaldi

NICE has published final guidance confirming its approval of Gilead’s controversial blockbuster hepatitis C treatment Sovaldi – but Gilead and …

News
jean-christophe_tellier_ucb_ceo

UCB’s new chief executive picked as EU rep for MISG

February 25, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jean-Christophe Tellier, MISG, UCB

UCB’s newly-appointed chief executive Jean-Christophe Tellier has been selected to join the Ministerial Industry Strategy Group (MISG). Elected to the …

Appointment
Shire image

Shire to buy Meritage Pharma

February 25, 2015
Research and Development, Sales and Marketing AbbVie, Meritage Pharma, Shire, eoe, gastrointestinal

Shire has purchased Meritage Pharma, a privately-held company specialising in gastrointestinal and skin diseases for $70 million. The acquisition means …

News
Avastin image

Doctors appeal to prescribe Avastin off-label

February 25, 2015
Sales and Marketing Lucentis, NHS, NICE, Novartis, Roche, bevacizumab, wet AMD

NHS Clinical Commissioners have called for the removal of barriers preventing CCGs from prescribing Roche’s Avastin to treat wet age-related …

News

FDA in Novartis cancer drug U-turn

February 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Farydak, Novartis, Revlimid, Velcade, myeloma

The FDA has overturned an earlier advisory committee recommendation and decided to approve Novartis’ blood cancer drug Farydak. In November …

News
Takeda image

Takeda acquires Turkish firm Neutec

February 24, 2015
Sales and Marketing Takeda, Turkey, gastroenterology, neutec, respiratory, turkish

Takeda has signed an agreement to acquire one of Turkey’s leading pharma firms Neutec in a $120 million deal. The …

News
Isentress image

Merck puts HIV drug in shared patent pool

February 24, 2015
Research and Development, Sales and Marketing AbbVie, Gilead, HIV, Merck, Raltegravir, Roche, isentress

Merck is teaming up with the Medicines Patent Pool (MPP) to license its paediatric HIV treatment in developing countries. The …

News
QELFA device

Novel device could help fight kidney disease

February 24, 2015
Research and Development, Sales and Marketing Bio Nano Consulting, Pfizer, QELFA, Rapamune, device, ime, kidney

A novel device that combines nanotechnology and a pregnancy tester could help treat kidney disease, according to a report by …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026